Intra-Cellular Therapies

+$0.23 (+0.54%) As of 4:54 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITCI and other ETFs, options, and stocks.

About ITCI

Intra-Cellular Therapies, Inc. operates as a biopharmaceutical company. It focuses on the discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders by targeting intracellular signaling mechanisms within the central nervous system, or CNS.

CEO
Sharon Mates
Employees
383
Headquarters
New York, New York
Founded
2013

ITCI Key Statistics

Market Cap
3.51B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
354.19K
High Today
$43.61
Low Today
$41.78
Open Price
$43.11
Volume
247.61K
52 Week High
$44.80
52 Week Low
$22.92

ITCI Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure